Home › NDC Lookup › Ingredients › Dextromethorphan Hydrobromide Guaifenesi... › 70692-0181-25
RIGHT REMEDIES Mucus Relief DM Dextromethorphan Hydrobromide, Guaifenesin 20 mg; 400 mg Tablet, 250-count — NDC 70692-0181-25 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

RIGHT REMEDIES Mucus Relief DM Dextromethorphan Hydrobromide, Guaifenesin 20 mg; 400 mg Tablet, 250-count — NDC 70692-181-25 (Billing 70692-0181-25)

by Strive Pharmaceuticals Inc. · 250 TABLET in 1 BOTTLE

This is a package of 250 tablets of RIGHT REMEDIES Mucus Relief DM Dextromethorphan Hydrobromide, Guaifenesin 20 mg; 400 mg Tablet from Strive Pharmaceuticals Inc., marketed since Jun 2026 and currently FDA-listed. It is the main listing for this product, which comes in 2 package sizes.

NDC 70692-0181-25
🏷️ FDA NDC (as labeled) 70692-181-25 billing pads the product segment with a zero
This package
Contains250-count Pack sizes2 compare ↓
Main listing for product 70692-181 · Also comes in: 180 tablets 70692-181-81
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Oct 1, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 70692-181-25
Product NDC 70692-181
11-digit billing NDC 70692018125
RxCUI 1147685
UNII 9D2RTI9KYH, 495W7451VQ
UPC 0370692001341
Application # M012
SPL Set ID 51c4dcfb-8725-d547-e063-6394a90ac04c
Established class (EPC) Expectorant
Physiologic effect Decreased Respiratory Secretion Viscosity; Increased Respiratory Secretions
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2026-06-01
Route ORAL
Dosage form TABLET
Substance DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN
Quick answers
  • RxCUI (RxNorm): 1147685
Why two NDCs? The FDA registers this code as 70692-181-25 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 70692-0181-25. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Uncompetitive N-methyl-D-aspartate Receptor Antagonist class.

Pharmacologic class Uncompetitive N-methyl-D-aspartate Receptor Antagonist, Sigma-1 Agonist
Drug family (ATC) Other antidepressants, Opium alkaloids and derivatives
How it works Uncompetitive NMDA Receptor Antagonists, Sigma-1 Receptor Agonists
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

📗 Our plain-language guide HelloPharmacist
  • It helps loosen mucus and makes coughs more productive. It also temporarily eases cough from minor throat and bronchial irritation, like with a cold or inhaled irritants.
  • Swallow them whole with a full glass of water. Don’t crush, chew or break them. You can take them with or without food, about every 12 hours as your label directs.
  • How do I take the extended-release tablets?
  • The extended-release tablets are not for children under 12. Some liquid products are made for children, so check that product’s label and ask me if you’re unsure.
📖 Read our full Dextromethorphan / Guaifenesin guide →

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eachPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Try another pack size: 180 tablets
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
70692-0181-25 You're viewing this Main listing 250 TABLET in 1 BOTTLE 2026-06-01 — Active
70692-0181-81 70692-181-81 180 TABLET in 1 BOTTLE 2026-06-01 — Active

You're viewing the largest of 2 pack sizes for this product.

Pack size FAQ

What quantity is in this package?
This is a 250-count package — 250 tablet in 1 bottle.
How does this package differ from NDC 70692-0181-81?
Both are RIGHT REMEDIES Mucus Relief DM Dextromethorphan Hydrobromide, Guaifenesin 20 mg; 400 mg Tablet — the drug itself is identical. This page's package is the 250-count one, while NDC 70692-0181-81 is the 180 tablets package.
What NDC number is used to bill for this package of RIGHT REMEDIES Mucus Relief DM Dextromethorphan Hydrobromide, Guaifenesin 20 mg; 400 mg Tablet?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Quality Choice Mucus Relief DM DM 20 mg/1; 400 mg 63868-0753-50 Chain 50 tablets $0.074 — FDA listed —
Sunmark Chest Congestion Relief DM DM 20 mg/1; 400 mg 49348-0728-09 Strategic 50 tablets $0.080 — FDA listed —
Rugby Chest Congestion Relief DM 20 mg/1; 400 mg 00536-1312-08 Rugby 60 tablets $0.082 — Availability likely —
Good Neighbor Pharmacy Mucus Relief DM 20 mg/1; 400 mg 24385-0026-71 AmerisourceBergen 50 tablets $0.082 — Availability likely —
Mucus Relief DM Cough 20 mg/1; 400 mg 46122-0790-61 Amerisource 50 tablets $0.082 — Availability likely —
Leader Chest Congestion Relief DM 20 mg/1; 400 mg 70000-0056-01 Cardinal 60 tablets $0.082 — Availability likely —
Mucus Relief DM Cough Maximum Strength 20 mg/1; 400 mg 70000-0278-01 Cardinal 12 tablets $0.082 — Availability likely —
Foster and Thrive Chest Congestion Relief DM DM 20 mg/1; 400 mg 70677-1055-01 Strategic 50 tablets $0.082 — Availability likely —
Quality Choice Mucus Relief DM DM 20 mg/1; 400 mg 83324-0195-50 Chain 50 tablets $0.082 — Availability likely —
Mucus Relief DM 20 mg/1; 400 mg 00363-0533-01 Walgreen 30 tablets — — FDA listed —
Refenesen Mucus Relief DM 20 mg/1; 400 mg 10956-0846-30 Reese 30 tablets — — FDA listed —
Pharbinex-Dm 400 mg/1; 20 mg 16103-0381-04 Pharbest 30 tablets — — FDA listed —
Mucus Relief Cough and Congestion DM 20 mg/1; 400 mg 17714-0150-60 Advance 60 tablets — — FDA listed —
Kroger Chest Congestion Relief DM 20 mg/1; 400 mg 30142-0472-30 THE 30 tablets — — FDA listed —
TopCare Chest Congestion and Cough Relief DM 20 mg/1; 400 mg 36800-0988-50 TOPCO 30 tablets — — FDA listed —
Mucus Relief Dm 20 mg/1; 400 mg 37835-0403-40 Bi-Mart 40 tablets — — FDA listed —
Equaline Chest Congestion Relief DM DM 20 mg/1; 400 mg 41163-0114-50 United 50 tablets — — FDA listed —
Mucus Relief Dm 20 mg/1; 400 mg 41226-0280-03 KROGER 30 tablets — — FDA listed —
Mucus Relief DM 20 mg/1; 400 mg 41250-0533-11 Meijer 60 tablets — — FDA listed —
Guaifenesin DM 400 mg/1; 20 mg 43063-0801-60 PD-Rx 60 tablets — — FDA listed —
Medique Medi-Mucus 20 mg/1; 400 mg 47682-0432-46 Unifirst 1 tablet — — FDA listed —
Mucosa Dm 400 mg/1; 20 mg 49483-0280-00 TIME 100000 tablets — — FDA listed —
Mucus Relief DM Immediate Release 20 mg/1; 400 mg 50804-0432-30 Good 30 tablets — — FDA listed —
Mucus Relief DM 20 mg/1; 400 mg 50804-0858-30 Good 30 tablets — — Discontinued —
Mucus Relief DM Cough 20 mg/1; 400 mg 50844-0633-11 L.N.K. 60 tablets — — FDA listed —
Mucosa DM 20 mg/1; 400 mg 54257-0277-01 Magno-Humphries, 50 tablets — — FDA listed —
Mucus Relief Cough and Congestion DM 20 mg/1; 400 mg 54738-0985-30 Richmond 30 tablets — — FDA listed —
Mucus Relief DM 20 mg/1; 400 mg 55301-0533-01 ARMY 10 tablets — — FDA listed —
Family Wellness Chest Congestion Relief DM DM 20 mg/1; 400 mg 55319-0890-30 Family 30 tablets — — FDA listed —
Dollar General Chest Congestion Relief DM 20 mg/1; 400 mg 55910-0272-30 Dolgencorp, 30 tablets — — FDA listed —
Chest Congestion Relief DM 20 mg/1; 400 mg 55910-0533-01 DOLGENCORP, 30 tablets — — FDA listed —
Guaifenesin and Dextromethorphan Hydrobromide 400 mg/1; 20 mg 57631-0013-10 InvaTech 26500 tablets — — FDA listed —
Mucus Relief Xpect 400 mg/1; 20 mg 63654-0342-20 Selder, 20 tablets — — FDA listed —
Always Save Chest Congestion Relief DM 20 mg/1; 400 mg 63941-0985-50 Valu 50 tablets — — FDA listed —
Marcs Chest Congestion Relief DM 20 mg/1; 400 mg 68998-0114-50 Marc 50 tablets — — FDA listed —
Mucus Relief DM Immediate Release 20 mg/1; 400 mg 69168-0432-07 Allegiant 10 tablets — — FDA listed —
CVS Chest Congestion Relief DM 20 mg/1; 400 mg 69842-0996-30 CVS 30 tablets — — FDA listed —
RIGHT REMEDIES Mucus Relief DM 20 mg/1; 400 mgthis 70692-0181-25 Strive 250 tablets — — FDA listed —
Mucus Relief Cough and Congestion DM 20 mg/1; 400 mg 71335-1928-01 Bryant 30 tablets — — FDA listed —
Rugby Chest Congestion Relief DM 20 mg/1; 400 mg 71335-2216-01 Bryant 30 tablets — — FDA listed —
Mucus Relief DM 20 mg/1; 400 mg 72090-0027-01 Pioneer 150 tablets — — FDA listed —
Care One Chest Congestion Relief DM 20 mg/1; 400 mg 72476-0871-50 RETAIL 50 tablets — — FDA listed —
Pharbinex-DM 400 mg/1; 20 mg 73057-0381-04 Ulai 30 tablets — — FDA listed —
Mucus Relief Xpect 400 mg/1; 20 mg 76095-0012-20 Midway 20 tablets — — FDA listed —
Mucus Relief DM 20 mg/1; 400 mg 76162-0008-01 TopCo 100 tablets — — FDA listed —
Mucus DM 20 mg/1; 400 mg 79481-5330-01 Meijer 60 tablets — — FDA listed —
Mucus Relief Dm 20 mg/1; 400 mg 80513-0407-09 Advanced 90 tablets — — FDA listed —
Mucus Relief DM 20 mg/1; 400 mg 84324-0035-01 NUVICARE 100 tablets — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2026
On the market since
Jun 2026
📍
2026
Currently FDA-listed
listed with the FDA
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerStrive Pharmaceuticals Inc.
FDA applicationM012 (OTC MONOGRAPH DRUG)
Labeler code70692
First marketedJun 2026
Product typeHuman Otc Drug
Portfolio31 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 📦 Storage and Handling 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Keep Out of Reach of Children 📄 Questions or Comments 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 61 words ▾

Uses • helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive • temporarily relieves: • cough due to minor throat and bronchial irritation as may occur with the common cold or inhaled irritants • the intensity of coughing • the impulse to cough to help you get to sleep

⏱️ Dosage and Administration 48 words ▾

Directions • do not exceed 6 tablets in 24 hours, unless directed by a doctor adults and children 12 years of age and over take 1 tablet every 4 hours with a full glass of water while symptoms persist c​hildren under 12 years of age do not use

⚠️ Warnings 185 words ▾

Warnings Do not use • if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product. Ask a doctor before use if you have • cough accompanied by too much phlegm (mucus) • persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis, or emphysema When using this product • do not use more than directed Stop use and ask a doctor if cough lasts more than 7 days, recurs, or is accompanied by fever, rash, or persistent headache.

These could be signs of a serious condition. If pregnant or breast-feeding, ask a health care professional before use. Keep out of reach of children.

Overdose warning: In case of overdose, get medical help or contact a Poison Control Center right away. Prompt medical attention is critical for adults as well as children even if you do not notice any signs or symptoms.

📦 Storage and Handling 19 words ▾

Other information • store at 20-25°C (68-77°F) • keep bottle tightly closed • protect from light, heat and moisture

🧪 Active Ingredient 12 words ▾

Active ingredients (in each tablet) Dextromethorphan HBr 20 mg Guaifenesin 400 mg

🧪 Inactive Ingredients 21 words ▾

Inactive ingredients colloidal silicon dioxide, hydroxypropyl methylcellulose, magnesium stearate, maltodextrin, microcrystalline cellulose, polyethylene glycol, polyvinyl pyrrolidone, sodium starch glycolate, stearic acid

🎯 Purpose 4 words ▾

Purposes Cough suppressant Expectorant

📄 Keep Out of Reach of Children 44 words ▾

Keep out of reach of children. Overdose warning: In case of overdose, get medical help or contact a Poison Control Center right away. Prompt medical attention is critical for adults as well as children even if you do not notice any signs or symptoms.

📄 Questions or Comments 9 words ▾

Questions or comments? 1 (888) 577-8033 Monday-Friday 8am-4pm EST

📄 Package Label / Principal Display Panel 5 words ▾

Packaging RR Mucus Relief DM

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for RIGHT REMEDIES Mucus Relief DM (this brand).

Top reported reactions

Blister1
Clonus1
Dermatitis1
Diarrhoea1
Drug Abuse1
Erythema1
Fixed Eruption1

Reporter sex

5 reports

Serious outcomes

Hospitalization3
Reports over time (by year) — tap or hover for the count & year
2021 2022 2024 2026 1 0
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

About this NDC listing & data coverage

Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available.
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Strive Pharmaceuticals Inc.. Listing status can change — the directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 1 other package presentation of this same product, including 180 tablets (70692-0181-81). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
Strive Pharmaceuticals Inc. is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 70692-0180-14 · Strive 70692-0471-31 · Strive →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.